Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL6079890 | 0.99 | KCNH2 (0.67) | KCNH2SLC2A1 | |
| SCHEMBL6079896 | 0.84 | KCNH2 (0.81) | KCNH2SLC2A1 | |
| Hydrochloric Acid SCHEMBL6079482 | 0.84 | KCNH2 (0.80) | KCNH2SLC2A1 | |
| SCHEMBL6079603 | 0.83 | KCNH2 (0.78) | KCNH2SLC2A1 | |
| Hydrochloric Acid SCHEMBL6079413 | 0.82 | SLC2A1 (0.80) | KCNH2SLC2A1 | |
| SCHEMBL16274116 | 0.81 | KCNH2 (1.00) | KCNH2SLC2A1 | |
| SCHEMBL6079866 | 0.80 | KCNH2 (0.64) | KCNH2SLC2A1 | |
| Hydrochloric Acid SCHEMBL5794315 | 0.80 | KCNH2 (0.98) | KCNH2SLC2A1 | |
| Hydrochloric Acid SCHEMBL6079353 | 0.80 | KCNH2 (0.64) | KCNH2SLC2A1 | |
| SCHEMBL5745735 | 0.79 | KCNH2 (0.59) | KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060041123-A1 | Antibacterial agents | GLAXO GROUP LIMITED (GB) | 2006-02-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060041123-A1 | Antibacterial agents | NQO2, NRDC, IFNG | KCNH2 3365/4885SLC2A1 4409/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.